Mentioned:Healthcare Triangle$30M · Corporate M&A
Healthcare Triangle has signed a nonbinding letter of intent to acquire Roboticom's robotics and precision automation assets for up to $30 million in cash and equity. The transaction would combine Healthcare Triangle's AI and cloud capabilities with Roboticom's industrial automation technology serving aerospace, marine, composites, and advanced manufacturing customers.
What's happening
- Healthcare Triangle signed a nonbinding LOI to acquire Roboticom's intellectual property, trademarks, customer contracts, and business assets for up to $30 million in combined cash and equity.
- Roboticom, a Pisa, Italy-based provider, generated approximately $14.1 million in revenue and $6.9 million in gross margin during fiscal 2025, according to unaudited information from the ownership group.
- The transaction covers SandRob, ORTIS, and ScultoRob product lines serving aerospace, marine, composites, orthotics and prosthetics, automotive, and advanced manufacturing sectors.
- Roboticom management projects $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal 2029/30, though Healthcare Triangle has not endorsed these projections.
Why it matters
- Healthcare Triangle expands beyond healthcare IT into industrial automation, accessing established customer relationships and product lines serving defense-adjacent aerospace and advanced manufacturing supply chains.
- Roboticom's precision automation technology addresses specialized manufacturing processes requiring consistency and repeatability, capabilities increasingly valued by manufacturers evaluating automation solutions.
- The acquisition allows Healthcare Triangle to integrate its AI and cloud platform with proven industrial robotics technology, potentially creating a differentiated offering for manufacturing automation.
Going deeper
- The transaction does not necessarily involve acquiring the entire legal entity but rather specified customer contracts, IP, trademarks, and business assets from Fabrica Machinale Srl, an Epica International subsidiary.
- Roboticom maintains a commercial presence in Landrum, South Carolina, alongside its Italian manufacturing base.
- Healthcare Triangle's existing Cloud and Data Platform holds HITRUST Risk-based, two-year Certified status, positioning compliance-ready technology for integration with industrial systems.
Financial impact
- Up to $30 million in consideration payable through combination of cash and equity over time, with structure and timing not disclosed.
- Healthcare Triangle must secure acquisition financing, complete audit of target financials, and obtain required approvals before closing; timing not disclosed.
- Roboticom's $14.1 million fiscal 2025 revenue and EBITDA-positive operating performance would appear as acquired revenue and operating contribution upon consolidation, subject to closing and integration timeline.
The intrigue
- The LOI references possibility of future spin-off or public listing for Healthcare Triangle, but no such transaction has been agreed upon or committed.
The fine print
- The letter of intent is nonbinding, and no assurance exists that parties will execute a definitive agreement or complete the transaction.
- Roboticom's financial figures are unaudited and subject to confirmation through Healthcare Triangle's due diligence; no independent verification has been completed.
- Healthcare Triangle must confirm the seller's legal ownership of assets as part of due diligence and negotiate definitive transaction agreements.
Source: Pulse 2.0 · Sep 25, 2026 · Drafted with Claude, reviewed by Industrial Base Alpha.
